よむ、つかう、まなぶ。
会議資料 (69 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/shingi2/0000198856_00031.html |
| 出典情報 | 医療上の必要性の高い未承認薬・適応外薬検討会議（第57回 ） |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
を目指した研究班」, 2023 年 3 月
2)
PREEXPOSURE PROPHYLAXIS FOR THE PREVENTION OF HIV INFECTION IN THE
UNITED STATES-2021 UPDATE（Published by Centers for Disease Control and Prevention,
2021）
3)
BHIVA/BASHH guidelines on the use of HIV pre-exposure prophylaxis（PrEP）（Published by
British HIV Association, 2018）
4)
McCormack S et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-infection
(PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.
Lancet 2016; 387(10013): 53-60
5)
Grant RM et al. Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with
Men. N Engl J Med 2010; 363: 2587-99
6)
Baeten JM et al. Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and
Women. N Engl J Med 2012; 367: 399-410
7)
Damme LV et al. Preexposure Prophylaxis for HIV Infection among African Women. N Engl J
Med 2012; 367: 411-22
8)
Marrazzo JM et al. Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African
Women. N Engl J Med 2015; 372: 509-18
9)
Mizushima D et al. A four-year observation of HIV and sexually transmitted infections among
men who have sex with men before and during pre-exposure prophylaxis in Tokyo. J Infect
Chemother 2022; 28: 762-66
10) Preexposure Prophylaxis for the Prevention of HIV Infection: Evidence Report and Systematic
Review for the US Preventive Services Task Force. JAMA 2019; 321: 2214‒30
11) Fonner VA et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all
populations. AIDS 2016; 30: 1973-83
12) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition;
2020; p.1599-618
13) CONSOLIDATED GUIDELINES ON HIV PREVENTION, TESTING, TREATMENT,
SERVICE DELIVERY AND MONITORING（Published by World Health Organization, 2021）
14) EACS European AIDS Clinical Society Guidelines Version 11.1（Published by European AIDS
Clinical Society, 2022）
15) Tan DHS et al. Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational
postexposure prophylaxis（UPDATED VERSION, June 13, 2018）. CMAJ 2017; 189: p.E144858
16) PREVENT HIV BY PRESCRIBING PrEP（Published by Australasian Society for HIV, Viral
Hepatitis and Sexual Health Medicine, 2021）
17) HIV 感染症「治療の手引き」第 26 版. 日本エイズ学会 HIV 感染症治療委員会; 2022
18) Anderson PL et al. Emtricitabine-tenofovir exposure and pre-exposure prophylaxis efficacy in
20
69 / 204
2)
PREEXPOSURE PROPHYLAXIS FOR THE PREVENTION OF HIV INFECTION IN THE
UNITED STATES-2021 UPDATE（Published by Centers for Disease Control and Prevention,
2021）
3)
BHIVA/BASHH guidelines on the use of HIV pre-exposure prophylaxis（PrEP）（Published by
British HIV Association, 2018）
4)
McCormack S et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-infection
(PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.
Lancet 2016; 387(10013): 53-60
5)
Grant RM et al. Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with
Men. N Engl J Med 2010; 363: 2587-99
6)
Baeten JM et al. Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and
Women. N Engl J Med 2012; 367: 399-410
7)
Damme LV et al. Preexposure Prophylaxis for HIV Infection among African Women. N Engl J
Med 2012; 367: 411-22
8)
Marrazzo JM et al. Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African
Women. N Engl J Med 2015; 372: 509-18
9)
Mizushima D et al. A four-year observation of HIV and sexually transmitted infections among
men who have sex with men before and during pre-exposure prophylaxis in Tokyo. J Infect
Chemother 2022; 28: 762-66
10) Preexposure Prophylaxis for the Prevention of HIV Infection: Evidence Report and Systematic
Review for the US Preventive Services Task Force. JAMA 2019; 321: 2214‒30
11) Fonner VA et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all
populations. AIDS 2016; 30: 1973-83
12) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition;
2020; p.1599-618
13) CONSOLIDATED GUIDELINES ON HIV PREVENTION, TESTING, TREATMENT,
SERVICE DELIVERY AND MONITORING（Published by World Health Organization, 2021）
14) EACS European AIDS Clinical Society Guidelines Version 11.1（Published by European AIDS
Clinical Society, 2022）
15) Tan DHS et al. Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational
postexposure prophylaxis（UPDATED VERSION, June 13, 2018）. CMAJ 2017; 189: p.E144858
16) PREVENT HIV BY PRESCRIBING PrEP（Published by Australasian Society for HIV, Viral
Hepatitis and Sexual Health Medicine, 2021）
17) HIV 感染症「治療の手引き」第 26 版. 日本エイズ学会 HIV 感染症治療委員会; 2022
18) Anderson PL et al. Emtricitabine-tenofovir exposure and pre-exposure prophylaxis efficacy in
20
69 / 204